Risk factors for adverse outcomes at various phases of endoscopic ultrasound-guided treatment of pancreatic fluid collections: data from a multi-institutional consortium.

Tomotaka Saito Shunsuke Omoto Mamoru TakenakaMasahiro TsujimaeAtsuhiro MasudaTatsuya SatoTsuyoshi HamadaShogo OtaHideyuki ShiomiSho TakahashiToshio FujisawaKeito NakagawaSaburo MatsubaraShinya UemuraTakuji Iwashita Kensaku YoshidaAkinori MarutaMitsuru OkunoKeisuke IwataNobuhiko HayashiTsuyoshi MukaiHiroyuki Isayama Ichiro Yasuda Yousuke Nakainull null

Published in: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2023)

The adverse outcomes at various phases of EUS-guided PFC treatment may be predictable based on clinical parameters. Further research is warranted to optimize treatment strategies for high-risk patients (registration number, UMIN000044130).

Keyphrases

ultrasound guided
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
fine needle aspiration
combination therapy
peritoneal dialysis
prognostic factors
big data
patient reported